SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiageo Regulatory News (DGE)

Share Price Information for Diageo (DGE)

Share Price is delayed by 15 minutes
Get Live Data
1,514.50    8.00 (0.53%)
Bid:
1,516.00
Ask:
1,517.00
Spread: 1.00 (0.066%)
Market Cap: £33.68b
DGE Live PriceLast checked at - London Stock Exchange

Intraday Diageo Share Chart

Publication of Final Terms

3 Oct 2025 13:35

RNS Number : 0508C
Diageo PLC
03 October 2025
 

 

 

 

 

3 October 2025

 

 

 

 

Publication of Final Terms

 

The Final Terms dated 1 October 2025 relating to the issuance by Diageo Finance plc ("the Issuer") of (i) EUR 500,000,000 3.250% Fixed Rate Instruments due 3 October 2032, and (ii) EUR 500,000,000 3.750% Fixed Rate Instruments due 3 October 2037 (together the "Instruments"), guaranteed by Diageo plc (the "Guarantor") are available for viewing.

 

The Instruments have been issued under the European Debt Issuance Programme established by the Issuer and the Guarantor (the "Programme").

 

The Final Terms should be read and construed in conjunction with the base prospectus dated 20 August 2025 in relation to the Programme (the "Base Prospectus").

 

To view the full documents, please paste the following URLs into the address bar of the browser:

 

§ http://www.rns-pdf.londonstockexchange.com/rns/0508C_1-2025-10-3.pdf

§ http://www.rns-pdf.londonstockexchange.com/rns/0508C_2-2025-10-3.pdf

 

 

Copies of the Final Terms have been submitted to the National Storage Mechanism and will shortly be available for inspection at:

 

https://data.fca.org.uk/#/nsm/nationalstoragemechanism

 

 

 

For further information, please contact:

 

Investor relations:

Sonya Ghobrial

Andy Ryan

Grace Murphy

 

 

+44 (0) 7392 784 784

+44 (0) 7803 854 842

+44 (0) 7514 726 167

investor.relations@diageo.com

Media relations:

Rebecca PerryClare Cavana

Isabel Batchelor

+44 (0) 7590 809 101

+44 (0) 7751 742 072

+44 (0) 7731 988 857press@diageo.com

 

 

About Diageo

 

Diageo is a global leader in beverage alcohol with an outstanding collection of brands across spirits and beer categories. These brands include Johnnie Walker, Crown Royal, JεB and Buchanan's whiskies, Smirnoff, Cîroc and Ketel One vodkas, Captain Morgan, Baileys, Don Julio, Tanqueray and Guinness.

 

Diageo is a global company, and our products are sold in nearly 180 countries around the world. The company is listed on both the London Stock Exchange (DGE) and the New York Stock Exchange (DEO). For more information about Diageo, our people, our brands, and performance, visit us at www.diageo.com. Visit Diageo's global responsible drinking resource, www.DRINKiQ.com for information, initiatives, and ways to share best practice.

 

Celebrating life, every day, everywhere.

 

Diageo plc

 

LEI: 213800ZVIELEA55JMJ32

 

Diageo Finance plc

 

LEI: BPF79TJMIH3DK8XCKI50

 

 

 

IMPORTANT: You must read the following before continuing: The following applies to the Final Terms available by clicking on the link above, and you are therefore advised to read this carefully before reading, accessing or making any other use of the Final Terms. In accessing the Final Terms, you agree to be bound by the following terms and conditions, including any modifications to them, any time you receive any information from us as a result of such access.

 

THE FINAL TERMS MAY NOT BE FORWARDED OR DISTRIBUTED OTHER THAN AS PROVIDED BELOW AND MAY NOT BE REPRODUCED IN ANY MANNER WHATSOEVER. THE FINAL TERMS MAY ONLY BE DISTRIBUTED OUTSIDE THE UNITED STATES TO PERSONS THAT ARE NOT U.S. PERSONS AS DEFINED IN, AND IN RELIANCE ON, REGULATION S UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"). ANY FORWARDING, DISTRIBUTION OR REPRODUCTION OF THE FINAL TERMS IN WHOLE OR IN PART IS PROHIBITED. FAILURE TO COMPLY WITH THIS NOTICE MAY RESULT IN A VIOLATION OF THE SECURITIES ACT OR THE APPLICABLE LAWS OF OTHER JURISDICTIONS. NOTHING IN THIS ELECTRONIC PUBLICATION CONSTITUTES AN OFFER OF SECURITIES FOR SALE IN ANY JURISDICTION. ANY NOTES ISSUED OR TO BE ISSUED PURSUANT TO THE FINAL TERMS HAVE NOT BEEN, AND WILL NOT BE, REGISTERED UNDER THE SECURITIES ACT OR THE SECURITIES LAWS OF ANY STATE OF THE UNITED STATES OR OTHER JURISDICTION. ANY INSTRUMENTS ISSUED OR TO BE ISSUED PURSUANT TO THE FINAL TERMS MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED EXCEPT IN AN OFFSHORE TRANSACTION TO A PERSON THAT IS NOT A U.S. PERSON IN ACCORDANCE WITH REGULATION S UNDER THE SECURITIES ACT.

 

Please note that the information contained in the Final Terms may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Final Terms and the Base Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Final Terms is not addressed. Prior to relying on the information contained in the Final Terms you must ascertain from the Base Prospectus whether or not you are part of the intended addressees of the information contained therein.

 

 

The Final Terms do not constitute, and may not be used in connection with, an offer or solicitation in any place where offers or solicitations are not permitted by law. If a jurisdiction requires that the offering be made by a licensed broker or dealer and the underwriters or any

affiliate of the underwriters is a licensed broker or dealer in that jurisdiction, the offering shall be deemed to be made by the underwriters or such affiliate on behalf of the issuer in such jurisdiction. Under no circumstances shall the Final Terms constitute an offer to sell, or the solicitation of an offer to buy, nor shall there be any sale of any Instruments issued or to be issued pursuant to the Final Terms, in any jurisdiction in which such offer, solicitation or sale would be unlawful.

 

The Final Terms have been made available to you in an electronic form. You are reminded that documents transmitted via this medium may be altered or changed during the process of electronic transmission and consequently none of the Issuers, the Guarantor, their advisers nor any person who controls any of them nor any director, officer, employee nor agent of it or affiliate of any such person accepts any liability or responsibility whatsoever in respect of any difference between the Final Terms made available to you in electronic format and the hard copy version available to you on request.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PFTBDBDGDXGDGUX
Date   Source Headline
11th Jun 20261:56 pmRNSDirector/PDMR Shareholding
10th Jun 20265:15 pmRNSDirector/PDMR Shareholding
1st Jun 202611:38 amRNSTotal Voting Rights
21st May 20267:22 amRNSSterling equivalent of Interim Dividend
19th May 20261:08 pmRNSDirector/PDMR Shareholding
18th May 20261:33 pmRNSDirector/PDMR Shareholding
15th May 20262:19 pmRNSDirector/PDMR Shareholding
11th May 20265:07 pmRNSDirector/PDMR Shareholding
11th May 20263:30 pmRNSDirector/PDMR Shareholding
6th May 20267:00 amRNSDiageo issues fiscal 26 Q3 trading statement
1st May 20262:13 pmRNSTotal Voting Rights
20th Apr 20264:49 pmRNSDirector/PDMR Shareholding
17th Apr 20264:39 pmRNSHolding(s) in Company
14th Apr 20269:52 amRNSDirector/PDMR Shareholding
10th Apr 20264:37 pmRNSDirector/PDMR Shareholding
1st Apr 202611:48 amRNSTotal Voting Rights
25th Mar 20267:00 amRNSDiageo subsidiary USL announces divesture in RCB
20th Mar 20263:29 pmRNSDirector/PDMR Shareholding
17th Mar 20263:00 pmRNSDirector/PDMR Shareholding
12th Mar 20265:35 pmRNSPublication of Supplement to Base Prospectus
10th Mar 20266:06 pmRNSDirector/PDMR Shareholding
10th Mar 20263:38 pmRNSDirector/PDMR Shareholding
10th Mar 202612:05 pmRNSDirector/PDMR Shareholding
10th Mar 202612:05 pmRNSDirector/PDMR Shareholding
2nd Mar 202612:55 pmRNSTotal Voting Rights
25th Feb 20267:00 amRNSInterim Results
19th Feb 20265:50 pmRNSDirector/PDMR Shareholding
13th Feb 20268:23 amRNSDirector Declaration
10th Feb 20266:03 pmRNSDirector/PDMR Shareholding
10th Feb 20261:53 pmRNSDirector/PDMR Shareholding
2nd Feb 20262:26 pmRNSTotal Voting Rights
21st Jan 20265:24 pmRNSDirector/PDMR Shareholding
20th Jan 20264:08 pmRNSDirector/PDMR Shareholding
20th Jan 20269:06 amRNSDirector Declaration
16th Jan 20269:31 amRNSDirector/PDMR Shareholding
16th Jan 20269:27 amRNSDirector/PDMR Shareholding
13th Jan 20264:44 pmRNSDirector/PDMR Shareholding
12th Jan 202611:54 amRNSDirector/PDMR Shareholding
5th Jan 20262:31 pmRNSBlock listing Interim Review
5th Jan 20262:26 pmRNSTotal Voting Rights
5th Jan 20268:30 amRNSDirector/PDMR Shareholding
19th Dec 202510:43 amRNSDirector/PDMR Shareholding
19th Dec 202510:43 amRNSDirector/PDMR Shareholding
17th Dec 20254:03 pmRNSDirector/PDMR Shareholding
17th Dec 20254:02 pmRNSDirector/PDMR Shareholding
17th Dec 20259:01 amRNSDiageo agrees to sell EABL shareholding to Asahi
11th Dec 20251:39 pmRNSDirector/PDMR Shareholding
10th Dec 202510:28 amRNSDirector/PDMR Shareholding
8th Dec 202512:46 pmRNSDirector Declaration
1st Dec 20253:24 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.